Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep Apnoea
Public ClinicalTrials.gov record NCT01557166. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in North America. The aim of the trial is to investigate the effect of liraglutide in obese subjects with sleep apnoea.
Study identification
- NCT ID
- NCT01557166
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 359 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 7, 2012 (Actual)
- Primary completion
- Jun 1, 2013 (Actual)
- Completion
- Jun 17, 2013 (Actual)
- Last update posted
- Nov 1, 2017
2012 – 2013
United States locations
- U.S. sites
- 37
- U.S. states
- 18
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Glendale | California | 91206 | — |
| Novo Nordisk Investigational Site | Oceanside | California | 92054 | — |
| Novo Nordisk Investigational Site | Orange | California | 92868 | — |
| Novo Nordisk Investigational Site | Redwood City | California | 94063 | — |
| Novo Nordisk Investigational Site | San Diego | California | 92103-5801 | — |
| Novo Nordisk Investigational Site | Santa Monica | California | 90404 | — |
| Novo Nordisk Investigational Site | Brandon | Florida | 33511 | — |
| Novo Nordisk Investigational Site | Hollywood | Florida | 33024 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33155 | — |
| Novo Nordisk Investigational Site | South Miami | Florida | 33143 | — |
| Novo Nordisk Investigational Site | St. Petersburg | Florida | 33707 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33603 | — |
| Novo Nordisk Investigational Site | West Palm Beach | Florida | 33409 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30342 | — |
| Novo Nordisk Investigational Site | Macon | Georgia | 31201 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60634 | — |
| Novo Nordisk Investigational Site | Vernon Hills | Illinois | 60061 | — |
| Novo Nordisk Investigational Site | Overland Park | Kansas | 66212 | — |
| Novo Nordisk Investigational Site | Crestview Hills | Kentucky | 41017-3464 | — |
| Novo Nordisk Investigational Site | Louisville | Kentucky | 40218 | — |
| Novo Nordisk Investigational Site | Chevy Chase | Maryland | 20815-6905 | — |
| Novo Nordisk Investigational Site | North Dartmouth | Massachusetts | 02747 | — |
| Novo Nordisk Investigational Site | Portage | Michigan | 49024-4889 | — |
| Novo Nordisk Investigational Site | Chesterfield | Missouri | 63017 | — |
| Novo Nordisk Investigational Site | New York | New York | 10019 | — |
| Novo Nordisk Investigational Site | New York | New York | 10065 | — |
| Novo Nordisk Investigational Site | Wilmington | North Carolina | 28401 | — |
| Novo Nordisk Investigational Site | Dublin | Ohio | 43017-3521 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19104-3317 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19118 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19140 | — |
| Novo Nordisk Investigational Site | Warwick | Rhode Island | 02886 | — |
| Novo Nordisk Investigational Site | Columbia | South Carolina | 29201-2951 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75231 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75234 | — |
| Novo Nordisk Investigational Site | Fort Worth | Texas | 76135 | — |
| Novo Nordisk Investigational Site | Vienna | Virginia | 22182 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01557166, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2017 · Synced Nov 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01557166 live on ClinicalTrials.gov.